Literature DB >> 1408291

[Liposomal amphotericin B in the treatment of candida infection in a 3-month-old infant].

W Emminger1, A Innerhofer, A Helfert, M Kummer, H Gadner.   

Abstract

Amphotericin B (Amph-B) is the treatment of choice for systemic fungal infections. The application of high doses is limited due to the high incidence of acute side effects (fever, chills) and organ toxicity (reduction in glomerular filtration rate, renal tubular damage). Amph-B was applied without success in a three months old infant, who suffered from systemic candidiasis. After a change to high doses (3-5 mg/kg/day) of liposomal Amph-B (Amph-lip) rapid improvement of the patient's condition occurred and the pulmonary lesions disappeared during six weeks of treatment (total dose 185.5 mg/kg). Acute side effects or renal function abnormalities did not occur. The reported case indicates that the application of high doses of Amph-lip is an alternative to conventional Amph-B in treatment of systemic fungal infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1408291

Source DB:  PubMed          Journal:  Padiatr Padol        ISSN: 0030-9338


  1 in total

1.  Tolerance of high doses of amphotericin B by infusion of a liposomal formulation in children with cancer.

Authors:  W Emminger; W Graninger; W Emminger-Schmidmeier; A Zoubek; K Pillwein; M Susani; A Wasserer; H Gadner
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.